Nuveen Asset Management, LLC Atara Biotherapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.41 - $2.31 $97,494 - $159,724	69,145 Added 108.51%	132,865 $196,000
Q2 2023 Aug 14, 2023	SELL	$1.5 - $3.04 $2.4 Million - $4.86 Million	-1,598,392 Reduced 96.17%	63,720 $102,000
Q1 2023 May 15, 2023	BUY	$2.8 - $5.46 $1.08 Million - $2.11 Million	387,265 Added 30.38%	1,662,112 $4.82 Million
Q4 2022 Feb 14, 2023	BUY	$2.85 - $5.18 $2.14 Million - $3.9 Million	752,345 Added 143.99%	1,274,847 $4.18 Million
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $3,066 - $9,393	1,076 Added 0.21%	522,502 $1.98 Million

Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $2.55 Million - $5.35 Million	-543,744 Reduced 51.05%	521,426 $4.06 Million
Q1 2022 May 16, 2022	SELL	$8.44 - $16.89 $804,247 - $1.61 Million	-95,290 Reduced 8.21%	1,065,170 $10 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $19.89 $1.47 Million - $1.98 Million	99,721 Added 9.4%	1,160,460 $18.3 Million
Q3 2021 Nov 12, 2021	SELL	$11.99 - $17.9 $1.04 Million - $1.56 Million	-86,968 Reduced 7.58%	1,060,739 $19 Million
Q2 2021 Aug 16, 2021	BUY	$12.89 - $16.58 $340,424 - $437,877	26,410 Added 2.36%	1,147,707 $17.8 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $20.72 $1.2 Million - $1.78 Million	85,941 Added 8.3%	1,121,297 $16.1 Million
Q4 2020 May 17, 2021	SELL	$12.67 - $26.23 $410,837 - $850,533	-32,426 Reduced 3.04%	1,035,356 $20.3 Million
Q4 2020 Feb 16, 2021	BUY	$12.67 - $26.23 $3.56 Million - $7.37 Million	281,047 Added 35.72%	1,067,782 $21 Million
Q3 2020 Nov 16, 2020	BUY	$11.92 - $15.87 $4.48 Million - $5.96 Million	375,468 Added 91.3%	786,735 $10.2 Million
Q2 2020 Aug 14, 2020	BUY	$7.53 - $14.93 $43,094 - $85,444	5,723 Added 1.41%	411,267 $5.99 Million
Q1 2020 May 14, 2020	BUY	$5.69 - $17.78 $642,822 - $2.01 Million	112,974 Added 38.61%	405,544 $3.45 Million
Q4 2019 Feb 14, 2020	BUY	$10.89 - $16.79 $735,456 - $1.13 Million	67,535 Added 30.01%	292,570 $4.82 Million
Q3 2019 Nov 14, 2019	BUY	$12.03 - $19.94 $310,855 - $515,249	25,840 Added 12.97%	225,035 $3.18 Million
Q2 2019 Aug 15, 2019	BUY	$19.05 - $41.04 $3.79 Million - $8.17 Million	199,195 New	199,195 $4.01 Million

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

Eco R1 Capital, LLC San Francisco, CA

10.2M
Shares

$78.4 Million
0.2% of portfolio
Redmile Group, LLC San Francisco, CA

9.26M
Shares

$71.4 Million
0.25% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$52.7 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

6.58M
Shares

$50.7 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

6.51M
Shares

$50.2 Million
0.0% of portfolio

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account